|
Getting your Trinity Audio player ready...
|
Insulin Resistance & Neuronal Damage — The Research Evidence
Why Restoring Insulin Sensitivity Matters for Motor Neurone Health
Insulin is not merely a metabolic hormone — it is one of the brain and nervous system's most critical neuroprotective agents. Insulin receptors are distributed throughout both the central and peripheral nervous systems, and intact insulin signalling is essential for neuronal survival, axonal maintenance, neurite growth, and the suppression of neuronal apoptosis (programmed cell death). When insulin resistance develops — whether systemically or specifically within neural tissue — neurons lose access to these protective signals. The evidence below documents both the neuronal damage that insulin resistance causes, and the restorative potential when insulin sensitivity is recovered.
A Special Case: Post-Polio Syndrome
Among the estimated 12–20 million polio survivors worldwide, insulin resistance is a particularly significant worsening amplifier. Polio survivors whose acute infection killed a substantial proportion of their motor neurones spent the following decades compensating — surviving neurones sprouting new terminals to reinnervate orphaned muscle fibres, enlarging motor units to up to seven to ten times their normal size in the process. Those neurones are already operating at extreme metabolic overcapacity.
When insulin resistance is added to that burden, it withdraws the very signalling that keeps those overloaded neurones alive: the PI3K-Akt anti-apoptotic pathway, the neurotrophic support for axonal maintenance, and the glial housekeeping that clears the toxic debris that would otherwise accelerate their decline. The result is an acceleration of the motor unit failure that drives post-polio syndrome (PPS) progression — a second deterioration that current medicine has no disease-modifying treatment for.
The studies below document both the damage that insulin resistance inflicts on neuronal tissue, and the meaningful restoration of neuronal function that follows when insulin sensitivity is recovered. For polio survivors, this raises a clinically important possibility: that addressing insulin resistance through diet and lifestyle intervention — removing the metabolic burden that should never have been added to an already compromised nervous system — could slow, stabilise, or partially reverse the neurological decline that defines PPS. This is not a claim that IR remission cures post-polio syndrome. It is a well-supported proposal that it removes one of its most significant accelerants.
Peer-Reviewed Research — Seven Studies, 2004–2024
Study 01
Role for Neuronal Insulin Resistance in Neurodegenerative Diseases
When insulin signalling was experimentally eliminated from neurons, there was a complete loss of insulin-mediated activation of the PI3K pathway and a complete loss of the neuronal anti-apoptotic (cell death prevention) effect that insulin normally provides. In intact animals, this produced markedly reduced phosphorylation of Akt and GSK3β, leading to substantially increased phosphorylation of tau — the same protein whose abnormal accumulation is the hallmark of Alzheimer's disease and other neurodegenerative conditions. This study established that intact insulin signalling is an indispensable requirement for suppressing programmed neuronal death.
Study 02
Insulin Resistance in the Nervous System
Neurons throughout both the peripheral and central nervous systems express insulin receptors, and insulin signalling through the PI3K-Akt pathway is directly responsible for axonal growth, neuronal survival, and re-innervation — the process by which damaged nerve circuits attempt to repair themselves. When neurons develop insulin resistance, they lose their capacity to respond to insulin's neurotrophic properties, resulting in neuronal injury, progressive dysfunction, and the development of neuropathic disease states. Critically, the study reports that intrathecal infusion of low-dose insulin for one month significantly improved the function of both motor and sensory nerves in a diabetic animal model, measured by electrophysiology, and also prevented axonal atrophy of sensory nerves.
Study 03
A Role for Insulin in Diabetic Neuropathy
Insulin has been shown in multiple models to act as a neurotrophic factor — promoting neurite growth and formation, increasing neuronal survival, and activating the PI3K-Akt pathway that directly supports axonal maintenance and the suppression of apoptosis. Restoring insulin signalling through intranasal delivery showed protection against electrophysiological decline, loss of neuromuscular junctions, and measurable loss of motor function in diabetic animal models. Evidence from the landmark Diabetes Control and Complications Trial (DCCT) demonstrated that patients with intensive glycaemic control showed a 64% reduction in neuropathy over a five-year period compared to those on conventional management — a direct human demonstration that reducing insulin resistance protects neural tissue at scale.
Study 04
Post-Polio Syndrome Revisited
This paper identifies a critical convergence between the metabolic demands placed on surviving motor neurones — enlarged up to seven to tenfold through compensatory re-innervation after polio — and the additional metabolic stress imposed by ageing and by impairments in insulin signalling and mitochondrial dysfunction. The authors note explicitly that ageing leads to oxidative and metabolic stress via impairments in insulin signalling, and that this is compounded by the intrinsic neuronal stress of recovery-induced expansion of motor units, potentially triggering the second wave of neurodegeneration seen in post-polio syndrome. This is the mechanistic basis for the clinical proposal that correcting insulin resistance in polio survivors could reduce the metabolic pressure on already over-burdened surviving motor neurones.
Study 05
Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease
The brain requires insulin to support metabolism, neuronal survival, synaptic plasticity, myelin maintenance, growth and repair, and neuroprotection — and any intervention that enhances brain glucose utilisation and insulin signalling through the PI3K-Akt pathway should be regarded as a first-line candidate for neuroprotection. The authors note that insulin-resistance diseases — including Type 2 diabetes, metabolic syndrome, and MASLD — are all inter-related and may share common root causes, suggesting they could be managed by similar therapeutic strategies. Given that insulin resistance is reversible through dietary and lifestyle intervention, this framework directly supports the proposition that metabolic remission is also neurological remission.
Study 06
Insulin Resistance Turns Brain Cells Into Slobs — A Link Between Diet and Neurodegenerative Disease
Glial cells — the brain's housekeeping cells, responsible for clearing the toxic cellular debris that would otherwise damage neurons — become insulin resistant under a high-sugar diet, shifting from efficient clearance to impaired function, allowing damaging debris to accumulate. This provides a direct mechanistic link between dietary insulin resistance and the glial dysfunction that contributes to neurodegeneration, with the researchers noting that the consequence for neuronal health is profound and measurable. Crucially, the lead researcher stated explicitly that insulin resistance is reversible — and that improving insulin sensitivity has the potential to restore glial function and thereby protect neurons from the debris-driven damage that accelerates their decline.
Study 07
Potential Molecular Mechanism of Exercise Reversing Insulin Resistance and Improving Neurodegenerative Diseases
Insulin resistance has been detected in patients with ALS (amyotrophic lateral sclerosis — the most severe form of motor neurone disease) since 1984, and subsequent research has confirmed that chronic inflammation caused by ageing and chronic disease drives peripheral and central insulin resistance, ultimately impairing synaptic plasticity, neurotransmitter transport, and neuronal survival pathways. Multiple studies demonstrate that restoring insulin signalling — whether through metabolic intervention or exercise — enhances cognitive and motor performance in neurodegenerative disease models. The paper identifies the insulin/IRS/Akt pathway as the primary mechanism through which insulin exerts its neuroprotective influence, making it a direct therapeutic target for conditions where motor neurone survival is compromised.
Summary Conclusion
Across seven peer-reviewed sources spanning 2004–2024, a consistent picture emerges. Insulin signalling is not peripheral to neuronal health — it is central to it. Where insulin resistance develops, neurons lose their primary anti-apoptotic protection, axonal maintenance is compromised, glial housekeeping fails, and the metabolic demands placed on surviving neural circuits cannot be adequately met.
Where insulin sensitivity is restored — through dietary change, lifestyle intervention, or direct insulin delivery in experimental models — measurable neurological recovery follows.
For polio survivors whose remaining motor neurones are already operating at extreme metabolic capacity, the removal of insulin resistance as an additional burden is not a marginal consideration. It may be one of the most meaningful protective interventions available to them. The evidence presented here does not promise recovery. It establishes, clearly and across multiple independent research teams, that insulin resistance is a significant and removable accelerant of neuronal decline — and that removing it restores the very signalling pathways on which neuronal survival depends.